EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma and Urine Pharmacokinetics of Long‐Acting Injectable Omeprazole Following Intramuscular Administrations to Healthy Thoroughbred Horses

Caitlin Harding iD, Marjaana Viljanto iD, Pamela Hincks iD, Jocelyn Habershon-Butcher iD, Stuart W Paine iD

Journal of Veterinary Pharmacology and Therapeutics · 2025-05 · 48 (3) · 155-162

DOI: 10.1111/jvp.13494 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, online erschienen am 08.02.2025. Verfasst von Caitlin Harding und 4 weiteren Autor:innen. Beteiligte Einrichtung: LGC Limited, Fordham, UK. Hauptthemen laut MEDLINE: Omeprazole, Anti-Ulcer Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Horse Racing Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Omeprazole is a gastric acid secretion inhibitor used as an effective anti‐ulcer drug. Based on oral administration studies, its International Screening Limit (ISL) was established in plasma and urine at 1 ng/mL with a Detection Time (DT) of 48 h. A novel formulation of injectable omeprazole has since been released, and therefore, a pharmacokinetic study was performed to assess the DT above the ISL against current advice. Six Thoroughbred horses were given four repeated weekly intramuscular administrations of omeprazole (4 mg/kg). Plasma and urine omeprazole concentrations were measured by liquid chromatography–tandem mass spectrometry. Based on the current plasma and urine ISL (1 ng/mL), the DT for this long‐acting omeprazole formulation administered at 4 mg/kg once per week is greater than 384 h (16 days) in both plasma and urine. Thus realistically, despite the appeal of giving an injection once per week rather than oral medication daily over a long period of time, this would make treatment for horses in training with the long‐acting product challenging within the rules of racing. It would therefore most likely be used for horses outside of training, and the oral formulation would still be legitimately used during training.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OmeprazoleAnti-Ulcer AgentsAnimalsHorsesInjections, IntramuscularDelayed-Action PreparationsMaleFemaleHalf-LifeArea Under Curve

Stichwörter der Autor:innen

detection timehorseintramuscularomeprazolepharmacokinetics

Substanzen

OmeprazoleDelayed-Action PreparationsAnti-Ulcer Agents

Autor:innen und Institutionen

  • LGC Limited, Fordham, UK.
  • British Horse Racing Authority, London, UK.
  • School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, UK.

ORCID-Profile: Caitlin Harding, Marjaana Viljanto, Pamela Hincks, Jocelyn Habershon-Butcher, Stuart W Paine

Förderung

  • British Horse Racing Authority

Zitieren

APA

Harding, C., Viljanto, M., Hincks, P., Habershon-Butcher, J., & Paine, S. W. (2025). Plasma and Urine Pharmacokinetics of Long‐Acting Injectable Omeprazole Following Intramuscular Administrations to Healthy Thoroughbred Horses. Journal of Veterinary Pharmacology and Therapeutics, 48(3), 155-162. https://doi.org/10.1111/jvp.13494

Vancouver

Harding C, Viljanto M, Hincks P, Habershon-Butcher J, Paine SW. Plasma and Urine Pharmacokinetics of Long‐Acting Injectable Omeprazole Following Intramuscular Administrations to Healthy Thoroughbred Horses. Journal of Veterinary Pharmacology and Therapeutics. 2025;48(3):155-162. doi:10.1111/jvp.13494

BibTeX
@article{Harding2025,
  author = {Harding, Caitlin and Viljanto, Marjaana and Hincks, Pamela and Habershon-Butcher, Jocelyn and Paine, Stuart W},
  title = {Plasma and Urine Pharmacokinetics of Long‐Acting Injectable Omeprazole Following Intramuscular Administrations to Healthy Thoroughbred Horses},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2025},
  volume = {48},
  number = {3},
  pages = {155--162},
  doi = {10.1111/jvp.13494}
}
Kostenlos starten →